RushNet (RushNet) Gross-Profit-to-Asset % : 0.00% (As of . 20)

View and export this data going back to . Start your Free Trial

What is RushNet Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. RushNet's annualized Gross Profit for the quarter that ended in . 20 was $ Mil. RushNet's average Total Assets over the quarter that ended in . 20 was $ 0 Mil. Therefore, RushNet's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

RushNet Gross-Profit-to-Asset % Historical Data

The historical data trend for RushNet's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet Gross-Profit-to-Asset % Chart

RushNet Annual Data

Trend

Gross-Profit-to-Asset %

RushNet Quarterly Data

Gross-Profit-to-Asset %

Competitive Comparison of RushNet's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, RushNet's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RushNet's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RushNet's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where RushNet's Gross-Profit-to-Asset % falls into.

RushNet Gross-Profit-to-Asset % Calculation

RushNet's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: . 20 )	/	( (Total Assets (A: . 20 )	+	Total Assets (A: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

RushNet's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

RushNet Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of RushNet's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

RushNet (RushNet) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222

Website

https://www.rushnetinc.com

RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.